Industry Intelligence Pillar

Drug Discovery Technology Intelligence

VexASI tracks technology adoption across biotech and pharmaceutical R&D, from computational biology and molecular modeling to laboratory informatics and AI drug discovery workflows.

The technology stack behind modern drug discovery

Biotech and pharma organizations increasingly rely on AI-native discovery workflows, bioinformatics platforms, lab informatics, and laboratory automation systems. VexASI surfaces the evidence that shows where real software adoption pressure is building.

AI in pharmaceutical research

Track signals tied to AI drug discovery pipelines, molecular design platforms, and research workflow acceleration.

Bioinformatics platforms used by biotech firms

Monitor computational biology, scientific software, and data-platform demand indicators across biotech teams.

Signals of R&D technology adoption

Detect software-intent evidence around Benchling, Schrödinger, Medidata, Veeva, LIMS, ELN, and adjacent systems.

Laboratory automation systems

Understand where wet-lab and computational workflows are converging into modern R&D technology stacks.